Does inhaled nitric oxide improve survival in operated congenital disease with severe pulmonary hypertension?

Indian Heart Journal

Volumn 53, Issue 1, 2001, Pages 48-55

  Sharma, Rajesh ^a   Raizada, N ^a   Choudhary, S K ^a   Bhan, A ^a   Kumar, P ^a   Juneja, R ^a   Kothari, S S ^a   Saxena, A ^a   Venugopal, P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Congenital heart defects; Nitric oxide; Pulmonary hypertension

Indexed keywords

FENTANYL; GLYCERYL TRINITRATE; ISOPRENALINE; NITRIC OXIDE; PANCURONIUM; PROSTAGLANDIN E;

ARTICLE; BLOOD PRESSURE MONITORING; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG TOLERANCE; ECHOCARDIOGRAPHY; HOSPITAL DISCHARGE; HUMAN; INFANT; LUNG ARTERY PRESSURE; PRESCHOOL CHILD; PULMONARY HYPERTENSION; RESUSCITATION; SURVIVAL; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; NITRIC OXIDE;

EID: 0034961024     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wessel DL. Inhaled nitric oxide for the treatment of pulmonary hypertension before and after cardiopulmonary bypass. Crit Care Med 1993; 21 (Suppl): S344-S345
2. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ. Very low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994; 108: 487-494
3. Russell IA, Zwass MS, Fineman JR, Balea M, Rouine-Rapp K, Brook M, et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesth Analg 1998; 87: 46-51
4. Journois D, Pouard P, Mauriat P, Malhere T, Vouhe P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operation for congenital heart defects. J Thorac Cardiovasc Surg 1994; 107: 1129-1135
5. Curran RD, Mavroudis C, Backer CL, Sautel M, Zales VR, Wessel DL. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Ann Thorac Surg 1995; 60: 1765-1771
6. Choudhary SK, Bhan A, Sharma R, Mathur A, Airen B, Saxena A, et al. Repair of total anomalous pulmonary venous connection in infancy: experience from a developing country. Ann Thorac Surg 1999; 68: 155-159
7. Fixler DE, Carrell T, Browne R, Willis K, Miller WW. Oxygen consumption in infants and children during cardiac catheterization under different sedation regimens. Circulation 1974; 50: 788-794
8. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1942; 340: 819-820
9. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective vasodilatation in pulmonary hypertension. Lancet 1991; 538: 1173-1174
10. Rossaint R, Falke KJ, Lopex F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for adult respiratory distress syndrome. N Engl J Med 1993; 328: 399-405
11. Girard C, Lehot JJ, Pannetier JC, Filley S, Ffrench P, Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary arterial hypertension. Anesthesiology 1992; 77: 880-883
12. Frostell CG, Blomqvist H, Hedenstierna G, Lundberg, J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic vasoconstriction without causing systemic vasodilation. Anesthesiology 1993; 78: 427-435
13. Barefield ES, Karle VA, Phillips JB, Carlo WA. Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J Pediatr 1996; 129: 279-286
14. Day RW, Allen EM, Witte MK. A randomixed, controlled study of the 1-hour and 24-hour effects of inhaled nitric oxide therapy in children with acute hypoxemic respiratory failure. Chest 1997; 112: 1324-1331
15. Nakagawa TA, Morris A, Gomez RJ, Johnston SJ, Sharky PT, Zaritsky AL. Dose response to inhaled nitric oxide in pediatric patients with pulmonary hypertension and acute respiratory distress syndrome. J Pediatr 1997; 131: 63-69
16. Bhorade S, Christenson J, O' Connor M, Lavoie A, Pohlman A, Hall JB. Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med 1999; 159: 571-579
17. Planas A, Ussetti P, Varela, Abejo'n D, Gomez-Nieto J, Tejada J, et al. Inhaled nitric oxide in early severe allograft lung dysfunction (Abstr). J Heart Lung Transpl 1999; 18: 55
18. Clapp S, Perry BL, Farooki ZQ, Jackson WL, Karpawich PP, Hakimi M, et al. Down's syndrome, complete atrioventricular canal, and pulmonary vascular obstructive disease. J Thorac Cardiovasc Surg 1990; 100: 115-121
19. Yamaki S, Yasui H, Kado H, Yonenaga K, Nakamura Y, Kikuchi T, et al. Pulmonary vascular disease and operative indications in complete atrioventricular canal defect in early infancy. J Thorac Cardiovasc Surg 1993; 106: 398-405
20. Newfeld EA, Paul MM, Muster AJ, Idriss FS. Pulmonary vascular disease in complete transposition of the great arteries: a study of 200 patients. Am J Cardiol 1974; 34: 75-82
21. Yamaki S, Horiuchi T, Ishizawa E, Mohri H, Fukuda M, Tezuka F. Indication for total correction of complete transposition of the great arteries with pulmonary hypertension. J Thorac Cardiovasc Surg 1980; 79: 890-895
22. Paul MH, Wernovsky G. Transposition of Great Arteries. In: Emmanouilides GG, Riemenschneider TA, Allen HD, Gutgesell HP (eds). Moss and Adams Heart Disease in infants, children and adolescents, including the fetus and young adults. 5th Edition, Williams & Wilkins: Baltimore, 1995; p. 1171-1172
23. Yamaki S, Tsunemoto M, Shimada M, Ishizawa R, Endo M, Nakayama S, et al. Quantitative analysis of pulmonary vascular disease in total anomalous pulmonary venous connection in sixty infants. J Thorac Cardiovasc Surg 1992; 104: 728-735
24. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993; 88: 2128-2138
25. Stephens RJ, Freeman G, Evans MJ. Early response of lungs to low levels of nitrogen dioxide. Light and electron microscopy. Arch Environ Health 1972; 24: 160-179
26. Morrow PE, Utell MJ, Bauer MH, Smeglin AM, Frampton MW, Cox C, et al. Pulmonary performance of elderly normal subjects and subjects with chronic obstructive pulmonary disease exposed to 0.3 ppm nitrogen dioxide. Am Rev Respir Dis 1992; 145: 291-300
27. Atz AM, Adatia I, Wessel DL. Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg 1996; 62: 1759-1764
28. Yamaki S, Mohri H, Haneda K, Endo M, Akimoto H. Indications for surgery based on lung biopsy in cases of ventricular septal defect and/or patent ductus arteriosus with severe pulmonary hypertension. Chest 1989; 96: 31-39